Company: OXBRW
Filing Date: 2025-04-25
Form Type: S-3
Source: 0001641172-25-006293
Chunk: 29

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-04-25
Form: S-3
Chunk 29
---
 to one vote per share other than in the circumstances noted in the Articles); and |
| ● | establish requirements for proposing matters that can be acted on by shareholders at extraordinary general meetings.                                         |

However, under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our Articles for a proper purpose and for what they believe in good faith to be in the best interests of our company.

Trading

Our ordinary shares are listed on the NASDAQ Capital Market under the symbol “OXBR”.

Transfer Agent and Registrar

The transfer agent and registrar for our ordinary shares is Broadridge Financial Solutions; telephone+1 800 353 0103.

| 16 |

<div align='center'>SELLING SHAREHOLDER</div>

This prospectus relates to the resale, from time to time, of up to 1,411,768 ordinary shares by the selling shareholder identified below.

On February 24, 2025, we and the selling shareholder entered into a securities purchase agreement relating to the issuance and sale of ordinary shares and warrants to purchase ordinary shares (collectively, the “Offering”). The selling shareholder purchased approximately $3.0 million in the Offering, consisting of an aggregate of 705,884 ordinary shares, Series A ordinary share warrants to purchase up to an aggregate of 529,413 ordinary shares and Series B ordinary share warrants to purchase up to an aggregate of 882,355 ordinary shares. The combined effective Offering price for each ordinary share and the accompanying ordinary share warrants was $4.25. The Series A ordinary share warrants are immediately exercisable, expire two years from the initial exercise date and have an exercise price of $4.25 per share. The Series B ordinary share warrants will be exercisable on the earlier of the date of shareholder approval or six months from the date of issuance, expire five years from the initial exercise date and have an exercise price equal to the lower of (i) $5.00 and (ii) from and after the date the Company receives shareholder approval, $4.25 per share. The shares covered by this prospectus consist of the 1,411,768 ordinary shares issuable upon exercise of the Series A and Series B ordinary share warrants issued to the selling shareholder in the Offering.

The following table sets forth, as of the date of this prospectus, the name of the selling shareholder, the aggregate number of ordinary shares held by the selling shareholder immediately prior to the sale of the ordinary shares in this Offering, the number of ordinary shares that may